|Articles|May 13, 2014
PRA Adds Large Molecule Capabilities to US Laboratory
PRA announced the addition of capabilities and services to its Lenexa, KS location.
Advertisement
PRA, a clinical research organization, announced the addition of capabilities and services to its Lenexa, KS location. Now, in addition to the laboratory in Assen, The Netherlands offering full-service bioanalytical capabilities, the Lenexa, KS laboratory will now offer immunochemistry services. The additions solidify PRA as the only company in the world with full-service bioanalytical capabilities near its clinics to support rapid results from Phase I clinical studies in the US and Europe.
Read the full release here .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV PatientsSeptember 12th 2025
Latest NIMBLE Study Results Highlight Progress in gMG ResearchSeptember 12th 2025
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug TrialsSeptember 11th 2025
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
